XML 69 R58.htm IDEA: XBRL DOCUMENT v3.24.1.u1
FAIR VALUE MEASUREMENTS - Narrative (Details)
 3 Months Ended
Mar. 31, 2024
USD ($)
Mar. 31, 2023
USD ($)
Dec. 31, 2023
USD ($)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Contingent consideration $ 294,260,000   $ 288,657,000
Business Combination, Contingent Consideration, Liability, Current 21,700,000    
Business Combination, Contingent Consideration, Liability, Noncurrent 272,600,000    
Equity Securities without Readily Determinable Fair Value, Downward Price Adjustment, Annual Amount 0 $ 400,000  
Venture capital investment fund      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Investment owned, at fair value 5,400,000   $ 5,200,000
Committed capital 18,000,000    
Committed capital callable $ 12,400,000    
Product development and other milestone-based payments | Weighted average | Measurement Input, Probability of Success      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Contingent consideration liability, measurement input 0.90   0.89
Product development and other milestone-based payments | Weighted average | Measurement Input, Present-value Factor      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Contingent consideration liability, measurement input 0.060   0.058
Foreign exchange forward      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Derivative, notional amount $ 46,200,000   $ 39,500,000
Derivative, fair value 0   0
Gain (Loss) on derivative instruments, net, pretax 0 $ 0  
Thrive, Ashion and OmicEra | Fair value      
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]      
Contingent consideration $ 294,300,000   $ 288,700,000